Skip to main content

 Scientific publications

Absence of residual fluorescence in the surgical bed at near-infrared fluorescence imaging predicts negative margins at final pathology in patients treated with breast-conserving surgery for breast cancer.

Authors : Pop FC, Veys I, Vankerckhove S, Barbieux R, Chintinne M, Moreau M, Donckier V, Larsimont D, Bourgeois P, Liberale G
Year : 2021
Journal : Eur J Surg Oncol
Volume : 47
Pages : 269-275

A radical approach to achieve complete cytoreductive surgery improve survival of patients with advanced ovarian cancer.

Authors : Liberale G, Pop FC, Polastro L, Kerger J, Moreau M, Chintinne M, Larsimont D, Nogaret JM, Veys I
Year : 2020
Journal : J Visc Surg
Volume : 157
Pages : 79-86

Ex vivo indocyanine green fluorescence imaging for the detection of lymph node involvement in advanced-stage ovarian cancer.

Authors : Pop FC, Veys I, Gomez Galdon M, Moreau M, Larsimont D, Donckier V, Bourgeois P, Liberale G
Year : 2018
Journal : J Surg Oncol
Volume : 118(7)
Pages : 1163-1169

ICG fluorescence imaging as a new tool for optimization of pathological evaluation in breast cancer tumors after neoadjuvant chemotherapy.

Authors : Veys I, Pop FC, Barbieux R, Moreau M, Noterman D, De Neubourg F, Nogaret JM, Liberale G, Larsimont D, Bourgeois P
Year : 2018
Journal : PLoS One
Volume : 13
Pages : e0197857 (13pages)

The impact of breast MRI workup on tumor size assessment and surgical planning in patients with early breast cancer.

Authors : Pop FC, Stanciu-Pop C, Drisis S, Radermeker M, Vandemerckt C, Noterman D, Moreau M, Larsimont D, Nogaret JM, Veys I
Year : 2018
Journal : Breast J
Volume : 24
Pages : 927-933

ICG-fluorescence imaging for detection of peritoneal metastases and residual tumoral scars in locally advanced ovarian cancer: A pilot study.

Authors : Veys I, Pop FC, Vankerckhove S, Barbieux R, Chintinne M, Moreau M, Nogaret JM, Larsimont D, Donckier V, Bourgeois P, Liberale G
Year : 2018
Journal : J Surg Oncol
Volume : 117(2)
Pages : 228-235